Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 1.81% is 19% below its 5-year average of 2.24%, around the middle of its 5-year range (-3.49%–12.85%).
As of the fiscal period ended Tuesday, June 30, 2026. 75.97% below its 12-month average of 7.54%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 1.81%.
RETURN ON INVESTED CAPITAL (ROIC)
1.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
7.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
1.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
2.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-2.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-32.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-75.97%
CURRENT VS 3Y AVG
-0.35%
CURRENT VS 5Y AVG
-19.09%
CURRENT VS 10Y AVG
+170.63%
CURRENT VS 15Y AVG
+105.51%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 761 covered companies
CURRENT VS SECTOR MEDIAN
+105.21%
vs the sector median at left
Harrow Health, Inc.
Market Cap
$1.13B
Return on Invested Capital (ROIC)
1.81%
TTM Avg
7.54%
3Y Avg
1.82%
5Y Avg
2.24%
Market Cap
$1.13B
Return on Invested Capital (ROIC)
5.93%
TTM Avg
9.95%
3Y Avg
11.37%
5Y Avg
9.31%
Market Cap
$1.13B
Return on Invested Capital (ROIC)
-67.73%
TTM Avg
-67.73%
3Y Avg
-67.73%
5Y Avg
-67.73%
Market Cap
$1.12B
Return on Invested Capital (ROIC)
-8.86%
TTM Avg
-9.81%
3Y Avg
-9.88%
5Y Avg
-6.15%
Market Cap
$1.15B
Return on Invested Capital (ROIC)
3.72%
TTM Avg
3.50%
3Y Avg
1.32%
5Y Avg
-2.22%
Market Cap
$1.11B
Return on Invested Capital (ROIC)
4.80%
TTM Avg
-11.69%
3Y Avg
-3.45%
5Y Avg
0.45%
Market Cap
$1.15B
Return on Invested Capital (ROIC)
-12.53%
TTM Avg
-48.13%
3Y Avg
-43.32%
5Y Avg
-40.54%
Market Cap
$1.10B
Return on Invested Capital (ROIC)
-139.11%
TTM Avg
-85.10%
3Y Avg
-62.90%
5Y Avg
-49.14%
Market Cap
$1.09B
Return on Invested Capital (ROIC)
-42.98%
TTM Avg
-26.82%
3Y Avg
-23.95%
5Y Avg
-23.95%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Harrow Health, Inc. (HROW) | $1.13B | 1.81% | 7.54% | 1.82% | 2.24% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 5.93% | 9.95% | 11.37% | 9.31% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | -67.73% | -67.73% | -67.73% | -67.73% |
| OPKO Health, Inc. (OPK)vs › | $1.12B | -8.86% | -9.81% | -9.88% | -6.15% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 3.72% | 3.50% | 1.32% | -2.22% |
| STAAR Surgical Company (STAA)vs › | $1.11B | 4.80% | -11.69% | -3.45% | 0.45% |
| Nektar Therapeutics (NKTR)vs › | $1.15B | -12.53% | -48.13% | -43.32% | -40.54% |
| Replimune Group, Inc. (REPL)vs › | $1.10B | -139.11% | -85.10% | -62.90% | -49.14% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | -42.98% | -26.82% | -23.95% | -23.95% |
| IRadimed Corporation (IRMD)vs › | $1.08B | 20.18% | 20.20% | 19.35% | 14.75% |
ROIC
1.8%
ROE
-244.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 1.81% |
| 2026-03-31 | 8.55% |
| 2025-12-31 | 12.85% |
| 2025-09-30 | 9.35% |
| 2025-06-30 | 5.15% |
| 2025-03-31 | 1.58% |
| 2024-12-31 | 2.96% |
| 2024-09-30 | -3.49% |
| 2024-06-30 | -3.37% |
| 2024-03-31 | -3.04% |
| 2023-12-31 | 0.16% |
| 2023-09-30 | 1.32% |
| 2023-06-30 | 0.84% |
| 2023-03-31 | 0.51% |
| 2022-12-31 | 1.38% |
| 2022-09-30 | 2.39% |
| 2022-06-30 | -1.97% |
| 2022-03-31 | 0.90% |
| 2021-12-31 | 1.82% |
| 2021-09-30 | 6.49% |
| 2021-06-30 | 11.44% |
| 2021-03-31 | 8.04% |
| 2020-12-31 | 0.76% |
| 2020-09-30 | -2.66% |
| 2020-06-30 | -18.37% |
| 2020-03-31 | -13.44% |
| 2019-12-31 | -9.87% |
| 2019-09-30 | -17.61% |
| 2019-06-30 | -7.33% |
| 2019-03-31 | -6.78% |
| 2018-12-31 | -12.79% |
| 2018-09-30 | -25.35% |
| 2018-06-30 | -36.90% |
| 2018-03-31 | -59.95% |
| 2017-12-31 | -66.84% |
| 2017-09-30 | -67.07% |
| 2017-06-30 | -69.60% |
| 2017-03-31 | -78.79% |
| 2016-12-31 | -72.94% |
| 2016-09-30 | -108.46% |
| 2016-06-30 | -95.59% |
| 2016-03-31 | -76.84% |
| 2015-12-31 | -160.41% |
| 2015-09-30 | -109.48% |
| 2015-06-30 | -80.48% |
| 2015-03-31 | -153.07% |
| 2014-12-31 | -116.89% |
| 2014-09-30 | -85.78% |
| 2014-06-30 | -71.16% |
| 2014-03-31 | -61.97% |
| 2013-12-31 | -50.87% |
| 2013-09-30 | -44.37% |
| 2013-06-30 | -37.13% |
| 2013-03-31 | -28.80% |
| 2012-12-31 | -41.80% |
| 2012-09-30 | -28.10% |
| 2012-06-30 | -24.98% |
| 2010-09-30 | -1329.00% |
| 2010-06-30 | -388.89% |
| 2009-12-31 | -790.70% |
| 2009-09-30 | -388.14% |
| 2009-06-30 | -239.22% |
| 2009-03-31 | -151.36% |
| 2008-12-31 | -81.94% |
| 2008-09-30 | -69.65% |
| 2008-06-30 | -31.04% |
